BETP, GLP-1R Potentiator

Catalog No. size PriceQuantity
M60196-2S 2 mg solid $129
M60196-10S 10mg solid $535


Product Information
Molecular Weight: 406.42
Formula: C20H17F3N2O2S
Purity: ≥98%
CAS#: 1371569-69-5
Solubility: DMSO up to 100 mM
Chemical Name: 4-(3-(benzyloxy)phenyl)-2-(ethylsulfinyl)-6-(trifluoromethyl)pyrimidine
Storage: Powder: 4oC 1 year. DMSO: 4oC 3 month; -20oC 1 year.


Biological Activity:

BETP is positive allosteric modulator and partial agonist of the glucagon-like peptide 1 (GLP-1) receptor. It covalently modifies cysteines 347 and 438 in GLP-1R. Specificity studies have shown that it has no activity on GLP-2, GIP, PTH or glucagon receptors. BETP has been shown to potentiate GLP-1R–dependent intracellular calcium mobilization but not cAMP accumulation in response to GLP-1(7-36)NH2 in recombinant cell lines. Conversely, BETP can enhance cAMP efficacy of GLP-1(9-36)NH2 at GLP-1R but not intracellular calcium mobilization. BETP also potentiates cAMP production of the dual-acting GLP-1R/glucagon (GCG) receptor (GCGR) agonist oxyntomodulin at GLP-1R. It promotes GLP-1(9-36)NH2–mediated glucose-dependent insulin secretion in rodent and human islet preparations as well as in rodent models following intravenous administration.


How to Use:

In vitro: BETP was used at 5-20 µM in vitro and cellular assays.

In vivo: BETP was administered through intravenous administration at 5 mg/kg to Wistar rats for IVGTT (In Vivo Intravenous Glucose Tolerance Test). Formulation: 10% ethanol-Solutol, 20% polyethylene glycol-400, and 70% phosphate-buffered saline, pH 7.4.



  1. Sloop KW, et al. Novel small molecule glucagon-like peptide-1 receptor agonist stimulates insulin secretion in rodents and from human islets. (2010) Diabetes. 59(12):3099-107.
  2. Cheong YH, et al. Two small molecule agonists of glucagon-like peptide-1 receptor modulate the receptor activation response differently. (2012) Biochem Biophys Res Commun. 417(1):558-63.
  3.  Willard FS, et al. Small molecule allosteric modulation of the glucagon-like Peptide-1 receptor enhances the insulinotropic effect of oxyntomodulin. (2012) Mol Pharmacol. 82(6):1066-73.
  4. Nolte WM, et al. A potentiator of orthosteric ligand activity at GLP-1R acts via covalent modification. (2014) Nat Chem Biol. In press. 


Products are for research use only. Not for human use

Payment & Security

American Express Apple Pay Diners Club Discover Elo Google Pay JCB Mastercard PayPal Shop Pay Venmo Visa

Your payment information is processed securely. We do not store credit card details nor have access to your credit card information.

Estimate shipping

You may also like

Recently viewed